A specialty pharmaceutical company built on known molecules, engineered into differentiated products, with the structure and discipline to deliver them.
Complex injectables and differentiated formulations sit in a part of the pharmaceutical market with real, durable structural advantages — independent of any single product's performance.
Sterile and complex-injectable manufacturing carries real barriers — regulatory compliance, capital intensity, and technical difficulty — that keep these markets meaningfully less crowded than standard generics. The same complexity that slows new entrants protects margin for the companies that can execute.
Full new chemical entity development is commonly cited at roughly $2.6 billion and 10 to 15 years. Development built on known molecules under defined regulatory pathways is typically a small fraction of that capital and timeline — years, not a decade; tens of millions, not billions.
A significant wave of injectable and complex-drug patent expirations over the next several years is expanding the pool of molecules with established safety profiles and open commercial opportunity — a structural tailwind independent of any single product's performance.
Operations spanning the United Kingdom and India combine scientific expertise, regulatory strategy, intellectual property planning, and commercial insight under one team.
Business Development · Licensing · IP Strategy
Leads global business development and licensing negotiations, intellectual property strategy, and regulatory positioning across UK and EU markets — the commercial front door for partners and investors.
Owned Facility · 50+ Scientists
Our own state-of-the-art R&D laboratory — the scientific engine of the pipeline, executing formulation, analytical, and preclinical development day to day.
Next-generation and single-cell sequencing, Sanger sequencing, digital PCR
Cryo-electron microscopy, NMR spectroscopy, X-ray micro-CT
Proteomics, metabolomics & lipidomics, biologics characterization
Confocal & super-resolution imaging, scanning & transmission electron microscopy
High-content imaging, flow cytometry analysis & sorting
3D printing, microfluidics, transgenic animal models